Author:
de Castro Sonia,García-Aparicio Carlos,Van Laethem Kristel,Gago Federico,Lobatón Esther,De Clercq Erik,Balzarini Jan,Camarasa María-José,Velázquez Sonsoles
Reference39 articles.
1. The phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RT;Auwerx;J. Virol.,2004
2. 2′,5′-Bis-O-(tert-butyldimethylsilyl)-3′-spiro-5″-(4″-amino-1″,2″-oxathiole-2″,2″-dioxide) pyrimidine (TSAO) nucleoside analogues: highly selective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcriptase;Balzarini;Proc. Natl. Acad. Sci. U.S.A.,1992
3. Treatment of human immunodeficiency virus type 1 (HIV-1)-infected cells with combinations of HIV-1-specific inhibitors results in a different resistance pattern than does treatment with single-drug therapy;Balzarini;J. Virol.,1993
4. Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2′,5′-bis-O-(tert-butyldimethylsilyl)-3′-spiro-5″-(4″-amino-1″,2″-oxathiole-2″,2″-dioxide)]-β-d-pentofuranosyl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitors;Balzarini;Proc. Natl. Acad. Sci. U.S.A.,1993
5. The HIV-l-specific TSAO-purine analogues show a resistance spectrum that is different from that of the HIV-l-specific non-nucleoside analogues;Balzarini;Mol. Pharmacol.,1993
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献